Leading startups benefit from BaselArea.swiss
The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in the biotech sector, while almost all the Basel companies named have benefited directly or indirectly from BaselArea.swiss.
time for startup (img: Tashatuvango/shutterstock)
Seven companies from the canton of Basel-Stadt and two from the canton of Basel-Landschaft qualified for the Top 100 of Swiss startups. Now, Venturelab has published its latest ranking. Five biotech startups made it into the top 20 – and two of them are from Basel.
Polyneuron Pharmaceuticals AG (14th place) received support from the healthcare accelerator BaseLaunch, which is operated by BaselArea.swiss. The location promotion organization also directly provided services to Cellestia Biotech AG (19th place). With T3 Pharmaceuticals (24th place) and Anaveon AG (37th place) from Bottmingen BL, two other Basel companies supported by BaseLaunch made it into the top 40.
In this year’s top 40 Swiss startups are MaxWell Biosystems (33rd place) and Artidis (36th place). Alongside medtech company Resistell (34th place) from Muttenz BL, they too benefited from BaselArea.swiss. The same goes for the micro- and nanotechnology company Qnami (64th place) from Basel. Internet and mobile company MyCamper (87th place) rounds off the Basel region’s companies in the top 100.
The list is topped by four companies in the electronics/mechanics and medtech sectors. In first place is Lausanne drone provider Flyability, followed by medtech company Lunaphore, which also hails from Lausanne. Two German-Swiss companies are in places 3 and 4 – the Zurich medtech company Ava and flight devices provider Wingtra from Zug. The best biotech company in the ranking is Cutiss AG from Zurich in 6th place.
Share this article
You might also be interested in
The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...Read More
China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...Read More
RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...Read More
Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...Read More
Learn more about our AI Program for SMEsRead More